Eraxis

"In the clinical trial setting, patients taking Eraxis for the treatment of candidemia had improved efficacy versus those taking fluconazole, making Eraxis an important addition to the options in antifungal treatment," said Dr. Annette Reboli, head of the Division of Infectious Diseases at Cooper University Hospital in Camden, N.J., and lead clinical investigator, in a prepared statement.

Pfizer's Anti-Fungal Treatment Approved 2006

The medicine, Eraxis, was one of two late-stage drugs the New York- based drug giant received when it bought biotech boutique Vicuron last summer.

Pfizer's Anti-Fungal Treatment Approved 2006

Candidemia, the infection Eraxis treats, is one of the most deadly hospital-acquired infections, with a mortality rate of 40%.

Pfizer's Anti-Fungal Treatment Approved 2006

Eraxis is already on the market to fight other types of infections.

unknown title 2011

Top-line results from a phase 3 trial showed that Eraxis plus Vfend was no better than Vfend alone at treating invasive aspergillosis, a life-threatening fungal infection.

unknown title 2011

Going generic wouldn't have affected sales of Eraxis.

unknown title 2011

If the trial had showed a statistically significant reduction in mortality, Pfizer could have gotten Eraxis approved for the added indication.

unknown title 2011

Pfizer said today that Eraxis (anidulafungin) has been approved by the U.S. Food and

THE MEDICAL NEWS 2010

Represents worldwide revenues for pharmaceutical products launched since 2006: Chantix / Champix, Eraxis, Selzentry / Celsentri, Sutent, Thelin and Toviaz.

Digital50.com Digital 50 Daily Industry News RSS Feed 2009

Pfizer said today that Eraxis (anidulafungin) has been approved by the U.S.

THE MEDICAL NEWS 2009